Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
AHS Cancer Control Alberta
ClinicalTrials.gov Identifier:
NCT00314535
First received: April 11, 2006
Last updated: March 19, 2012
Last verified: March 2012
  Purpose

Magnetic resonance (MR) spectroscopic techniques are to be developed to obtain the best data possible at 3 Tesla (3T) for the prostate.


Condition
Healthy

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe

Further study details as provided by AHS Cancer Control Alberta:

Enrollment: 40
Study Start Date: July 2005
Study Completion Date: October 2008
Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Local Healthy Volunteers

Criteria

Inclusion Criteria:

  • Subject 18 years of age and over
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00314535

Locations
Canada, Alberta
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2
Sponsors and Collaborators
AHS Cancer Control Alberta
Investigators
Principal Investigator: Gino Fallone, PhD AHS Cancer Control Alberta
  More Information

No publications provided

Responsible Party: AHS Cancer Control Alberta
ClinicalTrials.gov Identifier: NCT00314535     History of Changes
Other Study ID Numbers: EX-0002 / 22073
Study First Received: April 11, 2006
Last Updated: March 19, 2012
Health Authority: Canada: Health Canada

ClinicalTrials.gov processed this record on April 17, 2014